MAIN ARTICLE
A positive test is not a lifelong verdict
Food allergy assessment usually combines the story of a child's symptoms with evidence of immune sensitization. A positive skin-prick test or peanut-specific IgE blood result can establish that the immune system recognizes peanut proteins. But sensitization is not the same thing as a proven clinical reaction on eating the food. Confusing the two may create years of avoidance, anxiety and expense for families whose children can actually tolerate peanuts.
Researchers at the Murdoch Children's Research Institute and National Allergy Centre of Excellence evaluated 1,275 infants through ten public pediatric hospitals. Among 778 who received an oral food challenge, 271 had a negative result and 507 reacted. The negative share was 34.8%. Importantly, the challenged children had histories suggesting peanut reactions plus positive sensitization tests; they were not a random sample of all infants. The figure therefore must not be interpreted as meaning that one in three confirmed peanut allergies everywhere is incorrect.
The investigators also found that skin-test measurements and peanut-specific antibody levels tended to be higher among children who reacted. Those measures, however, could not reliably predict the dose that would trigger a reaction or how severe it would become. Clinical decisions must bring these clues together rather than relying on one laboratory result as a complete answer.
















